Who is the CEO of Winston Pharmaceuticals, Inc.?

The CEO of Winston Pharmaceuticals, Inc. is Joel E. Bernstein.

What industry does Winston Pharmaceuticals, Inc. belong to?

Winston Pharmaceuticals, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector.

Where is Winston Pharmaceuticals, Inc. headquartered?

Winston Pharmaceuticals, Inc. is headquartered at 100 North Fairway Drive, Vernon Hills, US.

What is the IPO date of Winston Pharmaceuticals, Inc.?

Winston Pharmaceuticals, Inc. went public on June 5, 2023.

How many employees does Winston Pharmaceuticals, Inc. have?

Winston Pharmaceuticals, Inc. has approximately 9 full-time employees.

Winston Pharmaceuticals, Inc.

WPHM•PNK

Healthcare

Medical - Pharmaceuticals

$0.00

$0.00(0.00%)

Winston Pharmaceuticals, Inc. (WPHM) Company Profile & Overview

Explore Winston Pharmaceuticals, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Winston Pharmaceuticals, Inc. (WPHM) Company Profile & Overview

Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management. It focuses on pain indications, such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo-and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease, as well as niche indications. Winston Pharmaceuticals, Inc. was formerly known as Winston Laboratories, Inc. and changed its name to Winston Pharmaceuticals, Inc. in November 2008. The company was incorporated in 1998 and is headquartered in Vernon Hills, Illinois.

SectorHealthcare

IndustryMedical - Pharmaceuticals

CEOJoel E. Bernstein

Contact Information

https://www.winstonlabs.com

100 North Fairway Drive, Vernon Hills

Company Facts

9 Employees

IPO DateJun 5, 2023

CountryUS

Actively Trading

Frequently Asked Questions

;